risedronic acid has been researched along with Pancreatitis, Chronic in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Pancreatitis, Chronic: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babinets', LS | 2 |
| Semenova, IV | 2 |
| Borovyk, IO | 2 |
1 trial available for risedronic acid and Pancreatitis, Chronic
| Article | Year |
|---|---|
[Comparative analysis of programs of complete correction osteogenic in patients with chronic pancreatitis].
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Etidronic Acid; Female; Humans; Male; M | 2014 |
1 other study available for risedronic acid and Pancreatitis, Chronic
| Article | Year |
|---|---|
[Osteodeficiency in chronic pancreatitis: ways of correction].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density; Bone Density Conservation | 2014 |